{"chief_complaint_en": ["Weakness"], "content": {"about": {"evidence_based_medicine_en": "", "formula_en": "<div class='table-responsive'> <table class='table table-bordered table-hover'> <tbody> <tr> <th>Description</th> <th>Points assigned*</th> <th>Description</th> </tr> <tr> <td>Normal no complaints; no evidence of disease.</td> <td>100</td> <td rowspan='3'>Able to carry on normal activity and to work;<br /> no special care needed.</td> </tr> <tr> <td>Able to carry on normal activity; minor signs or symptoms of disease.</td> <td>90</td> </tr> <tr> <td>Normal activity with effort; some signs or symptoms of disease.</td> <td>80</td> </tr> <tr> <td>Cares for self; unable to carry on normal activity or to do active work.</td> <td>70</td> <td rowspan='3'>Unable to work; able to live<br /> at home and care for most personal needs;<br /> varying amount of assistance needed.</td> </tr> <tr> <td>Requires occasional assistance, but is able to care for most of his personal needs.</td> <td>60</td> </tr> <tr> <td>Requires considerable assistance and frequent medical care.</td> <td>50</td> </tr> <tr> <td>Disabled; requires special care and assistance.</td> <td>40</td> <td rowspan='5'>Unable to care for self;<br /> requires equivalent of institutional or hospital care;<br /> disease may be progressing rapidly.</td> </tr> <tr> <td>Severely disabled; hospital admission is indicated although death not imminent.</td> <td>30</td> </tr> <tr> <td>Very sick; hospital admission necessary; active supportive treatment necessary.</td> <td>20</td> </tr> <tr> <td>Moribund; fatal processes progressing rapidly.</td> <td>10</td> </tr> <tr> <td>Dead.</td> <td>0</td> </tr> </tbody> </table> <p>*% Survival correlates with points assigned.</p> </div>", "more_info_en": "<p>The lower the Karnofsky Scale, the worse the prognosis:</p> <ul> <li>Unable to tolerate therapies</li> <li>Survival rates decrease</li> </ul><p>Karnofsky vs. <calculator id='3170'>ECOG/Zubrod Scores</calculator></p> <div class='table-responsive'> <table class='table table-bordered table-hover'> <tbody> <tr> <th style='width:40%'><calculator id='3170'>ECOG PERFORMANCE STATUS</calculator></th> <th style='width:60%'>KARNOFSKY PERFORMANCE STATUS</th> </tr> <tr> <td rowspan='2'>0\u2014Fully active, able to carry on all pre-disease performance without restriction</td> <td>100\u2014Normal, no complaints; no evidence of disease</td> </tr> <tr> <td>90\u2014Able to carry on normal activity; minor signs or symptoms of disease</td> </tr> <tr> <td rowspan='2'>1\u2014Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work</td> <td>80\u2014Normal activity with effort, some signs or symptoms of disease</td> </tr> <tr> <td>70\u2014Cares for self but unable to carry on normal activity or to do active work</td> </tr> <tr> <td rowspan='2'>2\u2014Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours</td> <td>60\u2014Requires occasional assistance but is able to care for most of personal needs</td> </tr> <tr> <td>50\u2014Requires considerable assistance and frequent medical care</td> </tr> <tr> <td rowspan='2'>3\u2014Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours</td> <td>40\u2014Disabled; requires special care and assistance</td> </tr> <tr> <td>30\u2014Severely disabled; hospitalization is indicated although death not imminent</td> </tr> <tr> <td rowspan='2'>4\u2014Completely disabled; cannot carry on any selfcare; totally confined to bed or chair</td> <td>20\u2014Very ill; hospitalization and active supportive care necessary</td> </tr> <tr> <td>10\u2014Moribund</td> </tr> <tr> <td>5\u2014Dead</td> <td>0\u2014Dead</td> </tr> </tbody> </table> </div>", "references_list": {"Original/Primary Reference": [{"href": "", "text": "Karnofsky DA Burchenal JH. (1949). 'The Clinical Evaluation of Chemotherapeutic Agents in Cancer.' In: MacLeod CM (Ed), Evaluation of Chemotherapeutic Agents. Columbia Univ Press. Page 196."}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/2071835", "text": "Crooks, V, Waller S, et al. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991; 46: M139-M144."}, {"href": "http://www.ncbi.nlm.nih.gov/pubmed/8156514", "text": "Hollen PJ, Gralla RJ, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Cancer. 1994; 73: 2087-2098."}, {"href": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1003019/", "text": "O'Toole DM, Golden AM. Evaluating cancer patients for rehabilitation potential. West J Med. 1991; 155:384-387."}, {"href": "http://www.ncbi.nlm.nih.gov/pubmed/6699671", "text": "Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncology. 1984; 2:187-193."}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. David Karnofsky", "qa_en": "", "creator_info": {"about_en": "<p>David A. Karnofsky, MD, (d. 1969) was an oncologist at Sloan-Kettering Institute for Cancer Research. He specialized in cancer chemotherapy and affiliated with the division of experimental chemotherapy.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-david-karnofsky.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Karnofsky+DA%5BAuthor%5D"}}], "how_to_use": {"pearls_pitfalls_en": "<ul> <li>The Karnofsky Performance Status Scale (KPS) is used extensively and for many purposes, including response to chemotherapy in cancer and chronic disease assessment.</li> <li>It quantifies a patient's functional abilities and impact of treatments like chemotherapy on their basic functional capacities.</li> <li>It is sometimes also used prognostically and to help determine treatment.</li> </ul>", "use_case_en": "<p>Patients with advancing cancer or other chronic diseases \u2014 or even frailty progression in the elderly.</p>", "why_use_en": "<p>Performance status is highly correlated with survival time and need for services in the home. It may also help predict ability to thrive with invasive and intensive treatment.</p>"}, "next_steps": {"advice_en": "<p>The Karnofsky Performance Status Scale is clearly useful to clinicians, and either this or another functional status scale should be used to improve understanding of patient needs and abilities, as well as potentially to prognose. </p>", "critical_actions_en": "<p>The Karnofsky Scale and other performance scales should be used in the holistic assessment of cancer patients, though its accuracy as a prognostic tool in individual cases is not yet well proved. </p>", "management_en": "<p>We are unaware of validated management algorithms using the Karnofsky Scale.</p>"}}, "disease_en": ["Cancer", "Chemotherapy"], "favorite_id": 3168, "full_title_en": "Karnofsky Performance Status Scale", "input_schema": [{"label_en": "Patient Description", "options": [{"label": "Normal no complaints; no evidence of disease", "value": 100}, {"label": "Able to carry on normal activity; minor signs or symptoms of disease", "value": 90}, {"label": "Normal activity with effort; some signs or symptoms of disease", "value": 80}, {"label": "Cares for self; unable to carry on normal activity or to do active work", "value": 70}, {"label": "Requires occasional assistance, but is able to care for most of his personal needs", "value": 60}, {"label": "Requires considerable assistance and frequent medical care", "value": 50}, {"label": "Disabled; requires special care and assistance", "value": 40}, {"label": "Severely disabled; hospital admission is indicated although death not imminent", "value": 30}, {"label": "Very sick; hospital admission necessary; active supportive treatment necessary", "value": 20}, {"label": "Moribund; fatal processes progressing rapidly", "value": 10}, {"label": "Dead", "value": 0}], "show_points": false, "type": "radio", "name": "karnofsky", "optional": false}], "instructions_en": "For patients \u2265 16 years old. Useful to use over time to track disease progression.", "medium_description_en": "Determines ability of patient to tolerate chemotherapy.", "purpose_en": ["Prognosis"], "search_abbreviation_en": ["chemo", "chemotherapy", "ability", "special care"], "seo": {"meta_description_en": "The Karnofsky Performance Status Scale determines ability of patient to tolerate therapies in serious illness, specifically for chemotherapy.", "keywords_en": "karnofsky, chemo, performance status, cancer performance status, status scale, karnofsky performance status"}, "short_description_en": "Chemotherapy tolerance.", "short_title_en": "Karnofsky Scale", "slug": "karnofsky-performance-status-scale", "specialty_en": ["Hematology and Oncology", "Hospitalist Medicine", "Internal Medicine", "Palliative Care/Hospice", "Radiation Oncology"], "system_en": ["Oncologic"], "calc_type": "calculator", "dosing": false, "before_use": "", "md5": "5392fb3de36a9bca0ddbfcf263c7d57c", "related_calcs": [{"calcId": 3170, "short_title_en": "ECOG Performance Status", "slug": "eastern-cooperative-oncology-group-ecog-performance-status"}, {"calcId": 3176, "short_title_en": "Lansky Scale", "slug": "lansky-play-performance-scale-pediatric-functional-status"}, {"calcId": 3315, "short_title_en": "Khorana Risk Score for VTE", "slug": "khorana-risk-score-venous-thromboembolism-cancer-patients"}]}